01.10.2007 | Original Article
Cost-Effectiveness of Recombinant Activated Factor VII as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients in Germany
Erschienen in: European Journal of Trauma and Emergency Surgery | Ausgabe 5/2007
Einloggen, um Zugang zu erhalten